Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, The Lancet

RCT (7,763 included in the assessment of azithromycin) found no significant difference for 10 days of azithromycin vs usual care for mortality at 28 days (22% for both, p=0.50), hospital stay (10 days vs 11 days) or the proportion discharged alive at 28 days (RR 1.04, p=0.19).
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news